Brachytherapy involves radiation therapy using radioactive sources placed inside or next to the area requiring treatment. Brachytherapy is widely used in the treatment of cervical, prostate, breast, and skin cancer. It delivers higher radiation doses directly to the tumor while limiting exposure to nearby healthy tissue. This results in better survival and cure rates with minimal side effects compared to other radiation therapies.
Market key trends:
There has been an increased use of brachytherapy in the treatment of cancers in recent years. Advancements in brachytherapy technologies allow for more targeted radiation and precise dose delivery to tumors. Image-guided brachytherapy systems enable real-time tracking and visualization of radioactive sources inside the body during treatment. This ensures radiation is delivered exactly as planned and improves treatment outcomes. Manufacturers are also developing new radiation delivery methods such as high and low dose rate brachytherapy that can be used depending on the cancer type and stage. This has expanded the applications of brachytherapy and contributed to the accelerated growth of the overall brachytherapy market.
Segment Analysis
Breast cancer brachytherapy helps in delivering higher and more focused radiation dose to the site of tumor while minimizing radiation exposure to nearby healthy tissues. This makes it an effective treatment option for early stage breast cancer.
Key Takeaways
Global Brachytherapy Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The global brachytherapy market is estimated to be valued at US$ 972.21 Mn in 2023 and is expected to exhibit a CAGR of 19% over the forecast period 2023 to 2030.
Regional analysis
North America currently dominates the global brachytherapy market. However, Asia Pacific is expected to witness the fastest growth over the forecast period supported by growing healthcare expenditure, increasing patient awareness and improving access to advanced cancer care across developing nations.
Key players
Key players operating in the brachytherapy market are Varian Medical Systems, Elekta AB, Becton, Dickinson and Company, IsoRay, Inc., Eckert & Ziegler BEBIG, and iCAD. Varian Medical Systems and Elekta AB currently hold the leading market position with their diverse product portfolios for brachytherapy procedures.
Get More Insights On This Topic: https://www.ukwebwire.com/brachytherapy-market-scope/
Comments
0 comment